Dataset: Transcription profiling of human A549 lung cancer cells treated with actinomycin D and sapphyrin PCI-2050 a new class of tumor-selective inhibitors of gene expression.
The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050....
The goal of this project was to characterize changes in gene expression in response to the anti-cancer agent sapphyrin PCI-2050. Cultured A549 human lung cancer cells were treated with sapphyrin PCI-2050 or actinomycin D.
- Species:
- human
- Samples:
- 12
- Source:
- E-GEOD-6400
- PubMed:
- 17233922
- Updated:
- Dec.12, 2014
- Registered:
- Sep.21, 2014
Factors:
(via ArrayExpress)
Sample | Compound | Dose |
---|---|---|
GSE6400GSM147368 | sapphyrin PCI-2050 | 1.25 uM |
GSE6400GSM147369 | sapphyrin PCI-2051 | 1.25 uM |
GSE6400GSM147370 | sapphyrin PCI-2052 | 1.25 uM |
GSE6400GSM147520 | sapphyrin PCI-2053 | 2.5 uM |
GSE6400GSM147521 | sapphyrin PCI-2054 | 2.5 uM |
GSE6400GSM147522 | sapphyrin PCI-2055 | 2.5 uM |
GSE6400GSM147099 | actinomycin D | 5 ug/ml |
GSE6400GSM147099 | actinomycin D | 5 ug/ml |
GSE6400GSM147099 | actinomycin D | 5 ug/ml |
GSE6400GSM147365 | mannitol | 5% |
GSE6400GSM147365 | mannitol | 5% |
GSE6400GSM147365 | mannitol | 5% |